NCT00035009View on ClinicalTrials.gov

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)

PHASE3CompletedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

September 20, 2001

Primary Completion Date

December 22, 2003

Study Completion Date

March 24, 2004

Conditions
Major Depressive Disorder
Interventions
DRUG

MK0869, aprepitant

DRUG

Comparator: paroxetine HCL

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00035009 - Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059) | Biotech Hunter | Biotech Hunter